nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—ABCC4—Adefovir Dipivoxil—hepatitis B	0.264	0.63	CbGbCtD
Celecoxib—ALB—hepatitis B	0.26	1	CbGaD
Celecoxib—ABCC4—Lamivudine—hepatitis B	0.155	0.37	CbGbCtD
Celecoxib—CA6—saliva—hepatitis B	0.0115	0.218	CbGeAlD
Celecoxib—ORM1—saliva—hepatitis B	0.00613	0.116	CbGeAlD
Celecoxib—Frequent bowel movements—Telbivudine—hepatitis B	0.00607	0.0373	CcSEcCtD
Celecoxib—MAPK14—blood plasma—hepatitis B	0.00443	0.0838	CbGeAlD
Celecoxib—Stiffness—Telbivudine—hepatitis B	0.00376	0.0231	CcSEcCtD
Celecoxib—PDPK1—blood—hepatitis B	0.00304	0.0574	CbGeAlD
Celecoxib—Fracture—Adefovir Dipivoxil—hepatitis B	0.00292	0.018	CcSEcCtD
Celecoxib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.00292	0.018	CcSEcCtD
Celecoxib—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.00292	0.018	CcSEcCtD
Celecoxib—Myositis—Telbivudine—hepatitis B	0.00292	0.0179	CcSEcCtD
Celecoxib—Transaminases increased—Entecavir—hepatitis B	0.00286	0.0176	CcSEcCtD
Celecoxib—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.00272	0.0167	CcSEcCtD
Celecoxib—PDPK1—liver—hepatitis B	0.00238	0.0449	CbGeAlD
Celecoxib—ABCC4—blood plasma—hepatitis B	0.00227	0.0428	CbGeAlD
Celecoxib—CA5A—liver—hepatitis B	0.00223	0.0421	CbGeAlD
Celecoxib—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00208	0.0128	CcSEcCtD
Celecoxib—Influenza-like symptoms—Telbivudine—hepatitis B	0.002	0.0123	CcSEcCtD
Celecoxib—Sulfaphenazole—CYP2A6—hepatitis B	0.00182	1	CrCbGaD
Celecoxib—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00178	0.011	CcSEcCtD
Celecoxib—CA2—blood plasma—hepatitis B	0.00173	0.0326	CbGeAlD
Celecoxib—MAPK14—blood—hepatitis B	0.00162	0.0307	CbGeAlD
Celecoxib—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00159	0.00979	CcSEcCtD
Celecoxib—Suicide—Lamivudine—hepatitis B	0.00155	0.00954	CcSEcCtD
Celecoxib—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00153	0.00941	CcSEcCtD
Celecoxib—CYP2C9—blood plasma—hepatitis B	0.00146	0.0276	CbGeAlD
Celecoxib—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00141	0.00867	CcSEcCtD
Celecoxib—Hepatic failure—Entecavir—hepatitis B	0.00141	0.00864	CcSEcCtD
Celecoxib—Influenza like illness—Telbivudine—hepatitis B	0.00139	0.00853	CcSEcCtD
Celecoxib—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00137	0.00843	CcSEcCtD
Celecoxib—Completed suicide—Lamivudine—hepatitis B	0.00137	0.00842	CcSEcCtD
Celecoxib—Anaphylactoid reaction—Entecavir—hepatitis B	0.00131	0.00802	CcSEcCtD
Celecoxib—PTGS2—blood plasma—hepatitis B	0.00128	0.0241	CbGeAlD
Celecoxib—MAPK14—liver—hepatitis B	0.00127	0.024	CbGeAlD
Celecoxib—Sepsis—Telbivudine—hepatitis B	0.00124	0.00762	CcSEcCtD
Celecoxib—CA14—liver—hepatitis B	0.00124	0.0233	CbGeAlD
Celecoxib—Blood creatinine increased—Entecavir—hepatitis B	0.00118	0.00727	CcSEcCtD
Celecoxib—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00117	0.00719	CcSEcCtD
Celecoxib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00116	0.00709	CcSEcCtD
Celecoxib—Abdominal pain upper—Entecavir—hepatitis B	0.00115	0.00709	CcSEcCtD
Celecoxib—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00114	0.00699	CcSEcCtD
Celecoxib—CYP3A4—blood plasma—hepatitis B	0.00111	0.0211	CbGeAlD
Celecoxib—CA5B—blood—hepatitis B	0.00111	0.0209	CbGeAlD
Celecoxib—CYP2D6—blood plasma—hepatitis B	0.0011	0.0207	CbGeAlD
Celecoxib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00109	0.00668	CcSEcCtD
Celecoxib—Pancreatitis—Entecavir—hepatitis B	0.00107	0.00658	CcSEcCtD
Celecoxib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00105	0.00642	CcSEcCtD
Celecoxib—Migraine—Telbivudine—hepatitis B	0.00102	0.00628	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00102	0.00623	CcSEcCtD
Celecoxib—Hyperglycaemia—Entecavir—hepatitis B	0.000985	0.00605	CcSEcCtD
Celecoxib—Dysphonia—Lamivudine—hepatitis B	0.00098	0.00602	CcSEcCtD
Celecoxib—ORM1—blood—hepatitis B	0.000978	0.0185	CbGeAlD
Celecoxib—Abdominal pain upper—Telbivudine—hepatitis B	0.000948	0.00582	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.000935	0.00574	CcSEcCtD
Celecoxib—Haematuria—Entecavir—hepatitis B	0.000929	0.0057	CcSEcCtD
Celecoxib—Nasopharyngitis—Telbivudine—hepatitis B	0.000929	0.0057	CcSEcCtD
Celecoxib—Jaundice—Adefovir Dipivoxil—hepatitis B	0.000926	0.00569	CcSEcCtD
Celecoxib—Hepatobiliary disease—Entecavir—hepatitis B	0.000921	0.00566	CcSEcCtD
Celecoxib—Gastritis—Telbivudine—hepatitis B	0.000919	0.00564	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000916	0.00562	CcSEcCtD
Celecoxib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.000906	0.00556	CcSEcCtD
Celecoxib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000899	0.00552	CcSEcCtD
Celecoxib—Viral infection—Lamivudine—hepatitis B	0.000893	0.00548	CcSEcCtD
Celecoxib—Bone disorder—Lamivudine—hepatitis B	0.000893	0.00548	CcSEcCtD
Celecoxib—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.000892	0.00548	CcSEcCtD
Celecoxib—Hepatitis—Entecavir—hepatitis B	0.000874	0.00537	CcSEcCtD
Celecoxib—Drug interaction—Lamivudine—hepatitis B	0.000869	0.00534	CcSEcCtD
Celecoxib—Oedema peripheral—Entecavir—hepatitis B	0.000861	0.00529	CcSEcCtD
Celecoxib—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000853	0.00524	CcSEcCtD
Celecoxib—Hypercholesterolaemia—Lamivudine—hepatitis B	0.000852	0.00523	CcSEcCtD
Celecoxib—Hearing impaired—Lamivudine—hepatitis B	0.000847	0.0052	CcSEcCtD
Celecoxib—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000847	0.0052	CcSEcCtD
Celecoxib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000843	0.00517	CcSEcCtD
Celecoxib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000838	0.00515	CcSEcCtD
Celecoxib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000836	0.00514	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000834	0.00512	CcSEcCtD
Celecoxib—ABCC4—blood—hepatitis B	0.00083	0.0157	CbGeAlD
Celecoxib—Vasculitis—Lamivudine—hepatitis B	0.000826	0.00507	CcSEcCtD
Celecoxib—Eructation—Lamivudine—hepatitis B	0.000792	0.00486	CcSEcCtD
Celecoxib—Immune system disorder—Entecavir—hepatitis B	0.00079	0.00485	CcSEcCtD
Celecoxib—Neuropathy peripheral—Telbivudine—hepatitis B	0.000784	0.00482	CcSEcCtD
Celecoxib—Alopecia—Entecavir—hepatitis B	0.000773	0.00474	CcSEcCtD
Celecoxib—Mental disorder—Entecavir—hepatitis B	0.000766	0.0047	CcSEcCtD
Celecoxib—ORM1—liver—hepatitis B	0.000765	0.0144	CbGeAlD
Celecoxib—CA4—blood—hepatitis B	0.000763	0.0144	CbGeAlD
Celecoxib—Aplastic anaemia—Lamivudine—hepatitis B	0.000757	0.00465	CcSEcCtD
Celecoxib—Neuropathy—Lamivudine—hepatitis B	0.000757	0.00465	CcSEcCtD
Celecoxib—Hepatobiliary disease—Telbivudine—hepatitis B	0.000757	0.00465	CcSEcCtD
Celecoxib—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000732	0.00449	CcSEcCtD
Celecoxib—Mouth ulceration—Lamivudine—hepatitis B	0.000729	0.00448	CcSEcCtD
Celecoxib—Back pain—Adefovir Dipivoxil—hepatitis B	0.000718	0.00441	CcSEcCtD
Celecoxib—Hepatitis—Telbivudine—hepatitis B	0.000718	0.00441	CcSEcCtD
Celecoxib—Hypoaesthesia—Telbivudine—hepatitis B	0.000715	0.00439	CcSEcCtD
Celecoxib—Pharyngitis—Telbivudine—hepatitis B	0.000713	0.00438	CcSEcCtD
Celecoxib—Connective tissue disorder—Telbivudine—hepatitis B	0.000706	0.00433	CcSEcCtD
Celecoxib—Sepsis—Lamivudine—hepatitis B	0.0007	0.0043	CcSEcCtD
Celecoxib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000686	0.00422	CcSEcCtD
Celecoxib—Leukopenia—Entecavir—hepatitis B	0.000681	0.00418	CcSEcCtD
Celecoxib—Sleep disorder—Lamivudine—hepatitis B	0.000676	0.00415	CcSEcCtD
Celecoxib—ALB—liver—hepatitis B	0.000671	0.0127	CbGeAlD
Celecoxib—Gastroenteritis—Lamivudine—hepatitis B	0.00066	0.00405	CcSEcCtD
Celecoxib—Deafness—Lamivudine—hepatitis B	0.000654	0.00402	CcSEcCtD
Celecoxib—ABCC4—liver—hepatitis B	0.000649	0.0123	CbGeAlD
Celecoxib—Cough—Adefovir Dipivoxil—hepatitis B	0.000648	0.00398	CcSEcCtD
Celecoxib—Mediastinal disorder—Telbivudine—hepatitis B	0.000647	0.00398	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000644	0.00395	CcSEcCtD
Celecoxib—CA2—blood—hepatitis B	0.000633	0.012	CbGeAlD
Celecoxib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000632	0.00388	CcSEcCtD
Celecoxib—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000632	0.00388	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000628	0.00386	CcSEcCtD
Celecoxib—Anaphylactic shock—Entecavir—hepatitis B	0.000621	0.00381	CcSEcCtD
Celecoxib—Infection—Entecavir—hepatitis B	0.000617	0.00379	CcSEcCtD
Celecoxib—Dysgeusia—Telbivudine—hepatitis B	0.000612	0.00376	CcSEcCtD
Celecoxib—Nervous system disorder—Entecavir—hepatitis B	0.000609	0.00374	CcSEcCtD
Celecoxib—Back pain—Telbivudine—hepatitis B	0.000605	0.00371	CcSEcCtD
Celecoxib—Skin disorder—Entecavir—hepatitis B	0.000603	0.00371	CcSEcCtD
Celecoxib—Muscle spasms—Telbivudine—hepatitis B	0.000601	0.00369	CcSEcCtD
Celecoxib—Hypoglycaemia—Lamivudine—hepatitis B	0.0006	0.00368	CcSEcCtD
Celecoxib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000594	0.00365	CcSEcCtD
Celecoxib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000593	0.00364	CcSEcCtD
Celecoxib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000589	0.00362	CcSEcCtD
Celecoxib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000578	0.00355	CcSEcCtD
Celecoxib—Migraine—Lamivudine—hepatitis B	0.000576	0.00354	CcSEcCtD
Celecoxib—Insomnia—Entecavir—hepatitis B	0.000562	0.00345	CcSEcCtD
Celecoxib—Somnolence—Entecavir—hepatitis B	0.000552	0.00339	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000552	0.00339	CcSEcCtD
Celecoxib—Dyspepsia—Entecavir—hepatitis B	0.000547	0.00336	CcSEcCtD
Celecoxib—Cough—Telbivudine—hepatitis B	0.000546	0.00335	CcSEcCtD
Celecoxib—Liver function test abnormal—Lamivudine—hepatitis B	0.00054	0.00332	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Entecavir—hepatitis B	0.000536	0.00329	CcSEcCtD
Celecoxib—Fatigue—Entecavir—hepatitis B	0.000536	0.00329	CcSEcCtD
Celecoxib—CYP2C9—blood—hepatitis B	0.000535	0.0101	CbGeAlD
Celecoxib—Abdominal pain upper—Lamivudine—hepatitis B	0.000534	0.00328	CcSEcCtD
Celecoxib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000534	0.00328	CcSEcCtD
Celecoxib—Arthralgia—Telbivudine—hepatitis B	0.000532	0.00327	CcSEcCtD
Celecoxib—Myalgia—Telbivudine—hepatitis B	0.000532	0.00327	CcSEcCtD
Celecoxib—Chest pain—Telbivudine—hepatitis B	0.000532	0.00327	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000529	0.00325	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.000527	0.00324	CcSEcCtD
Celecoxib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000527	0.00324	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000523	0.00321	CcSEcCtD
Celecoxib—Nasopharyngitis—Lamivudine—hepatitis B	0.000523	0.00321	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.000516	0.00317	CcSEcCtD
Celecoxib—Gastrointestinal pain—Entecavir—hepatitis B	0.000508	0.00312	CcSEcCtD
Celecoxib—Dysphagia—Lamivudine—hepatitis B	0.000506	0.00311	CcSEcCtD
Celecoxib—Nervous system disorder—Telbivudine—hepatitis B	0.0005	0.00307	CcSEcCtD
Celecoxib—Thrombocytopenia—Telbivudine—hepatitis B	0.0005	0.00307	CcSEcCtD
Celecoxib—Pancreatitis—Lamivudine—hepatitis B	0.000496	0.00304	CcSEcCtD
Celecoxib—Skin disorder—Telbivudine—hepatitis B	0.000496	0.00304	CcSEcCtD
Celecoxib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000496	0.00304	CcSEcCtD
Celecoxib—CA2—liver—hepatitis B	0.000495	0.00935	CbGeAlD
Celecoxib—Sweating increased—Lamivudine—hepatitis B	0.000493	0.00303	CcSEcCtD
Celecoxib—Abdominal pain—Entecavir—hepatitis B	0.000491	0.00302	CcSEcCtD
Celecoxib—Body temperature increased—Entecavir—hepatitis B	0.000491	0.00302	CcSEcCtD
Celecoxib—Bronchitis—Lamivudine—hepatitis B	0.000486	0.00299	CcSEcCtD
Celecoxib—Pancytopenia—Lamivudine—hepatitis B	0.00048	0.00295	CcSEcCtD
Celecoxib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000479	0.00294	CcSEcCtD
Celecoxib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000479	0.00294	CcSEcCtD
Celecoxib—Dysuria—Lamivudine—hepatitis B	0.000473	0.0029	CcSEcCtD
Celecoxib—Pollakiuria—Lamivudine—hepatitis B	0.000467	0.00287	CcSEcCtD
Celecoxib—PTGS2—blood—hepatitis B	0.000467	0.00883	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000465	0.00286	CcSEcCtD
Celecoxib—Insomnia—Telbivudine—hepatitis B	0.000462	0.00283	CcSEcCtD
Celecoxib—Paraesthesia—Telbivudine—hepatitis B	0.000458	0.00281	CcSEcCtD
Celecoxib—Hyperglycaemia—Lamivudine—hepatitis B	0.000456	0.0028	CcSEcCtD
Celecoxib—Dyspepsia—Telbivudine—hepatitis B	0.000449	0.00276	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000447	0.00275	CcSEcCtD
Celecoxib—Asthenia—Entecavir—hepatitis B	0.000446	0.00274	CcSEcCtD
Celecoxib—Neuropathy peripheral—Lamivudine—hepatitis B	0.000442	0.00271	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000441	0.00271	CcSEcCtD
Celecoxib—Fatigue—Telbivudine—hepatitis B	0.00044	0.0027	CcSEcCtD
Celecoxib—Stomatitis—Lamivudine—hepatitis B	0.00044	0.0027	CcSEcCtD
Celecoxib—Jaundice—Lamivudine—hepatitis B	0.00044	0.0027	CcSEcCtD
Celecoxib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000435	0.00267	CcSEcCtD
Celecoxib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000429	0.00263	CcSEcCtD
Celecoxib—Hepatobiliary disease—Lamivudine—hepatitis B	0.000426	0.00262	CcSEcCtD
Celecoxib—Epistaxis—Lamivudine—hepatitis B	0.000425	0.00261	CcSEcCtD
Celecoxib—Diarrhoea—Entecavir—hepatitis B	0.000425	0.00261	CcSEcCtD
Celecoxib—Sinusitis—Lamivudine—hepatitis B	0.000423	0.0026	CcSEcCtD
Celecoxib—Agranulocytosis—Lamivudine—hepatitis B	0.000421	0.00258	CcSEcCtD
Celecoxib—Feeling abnormal—Telbivudine—hepatitis B	0.000421	0.00258	CcSEcCtD
Celecoxib—CYP2C9—liver—hepatitis B	0.000419	0.00791	CbGeAlD
Celecoxib—Gastrointestinal pain—Telbivudine—hepatitis B	0.000417	0.00256	CcSEcCtD
Celecoxib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000415	0.00255	CcSEcCtD
Celecoxib—Dizziness—Entecavir—hepatitis B	0.000411	0.00252	CcSEcCtD
Celecoxib—CYP3A4—blood—hepatitis B	0.000408	0.00771	CbGeAlD
Celecoxib—Rhinitis—Lamivudine—hepatitis B	0.000406	0.00249	CcSEcCtD
Celecoxib—Hepatitis—Lamivudine—hepatitis B	0.000405	0.00249	CcSEcCtD
Celecoxib—Abdominal pain—Telbivudine—hepatitis B	0.000403	0.00248	CcSEcCtD
Celecoxib—Body temperature increased—Telbivudine—hepatitis B	0.000403	0.00248	CcSEcCtD
Celecoxib—Hypoaesthesia—Lamivudine—hepatitis B	0.000403	0.00247	CcSEcCtD
Celecoxib—Pharyngitis—Lamivudine—hepatitis B	0.000402	0.00247	CcSEcCtD
Celecoxib—CYP2D6—blood—hepatitis B	0.000402	0.00759	CbGeAlD
Celecoxib—Connective tissue disorder—Lamivudine—hepatitis B	0.000398	0.00244	CcSEcCtD
Celecoxib—Vomiting—Entecavir—hepatitis B	0.000395	0.00243	CcSEcCtD
Celecoxib—Rash—Entecavir—hepatitis B	0.000392	0.00241	CcSEcCtD
Celecoxib—Dermatitis—Entecavir—hepatitis B	0.000391	0.0024	CcSEcCtD
Celecoxib—Headache—Entecavir—hepatitis B	0.000389	0.00239	CcSEcCtD
Celecoxib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000385	0.00237	CcSEcCtD
Celecoxib—Erythema multiforme—Lamivudine—hepatitis B	0.000383	0.00235	CcSEcCtD
Celecoxib—Rash—Adefovir Dipivoxil—hepatitis B	0.000382	0.00235	CcSEcCtD
Celecoxib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000382	0.00234	CcSEcCtD
Celecoxib—Headache—Adefovir Dipivoxil—hepatitis B	0.00038	0.00233	CcSEcCtD
Celecoxib—Nausea—Entecavir—hepatitis B	0.000369	0.00227	CcSEcCtD
Celecoxib—Asthenia—Telbivudine—hepatitis B	0.000366	0.00225	CcSEcCtD
Celecoxib—Immune system disorder—Lamivudine—hepatitis B	0.000366	0.00225	CcSEcCtD
Celecoxib—PTGS2—liver—hepatitis B	0.000365	0.0069	CbGeAlD
Celecoxib—Mediastinal disorder—Lamivudine—hepatitis B	0.000365	0.00224	CcSEcCtD
Celecoxib—Pruritus—Telbivudine—hepatitis B	0.000361	0.00222	CcSEcCtD
Celecoxib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00036	0.00221	CcSEcCtD
Celecoxib—Alopecia—Lamivudine—hepatitis B	0.000358	0.0022	CcSEcCtD
Celecoxib—Diarrhoea—Telbivudine—hepatitis B	0.000349	0.00214	CcSEcCtD
Celecoxib—Flatulence—Lamivudine—hepatitis B	0.000347	0.00213	CcSEcCtD
Celecoxib—Tension—Lamivudine—hepatitis B	0.000346	0.00212	CcSEcCtD
Celecoxib—Dysgeusia—Lamivudine—hepatitis B	0.000345	0.00212	CcSEcCtD
Celecoxib—Nervousness—Lamivudine—hepatitis B	0.000342	0.0021	CcSEcCtD
Celecoxib—Back pain—Lamivudine—hepatitis B	0.000341	0.00209	CcSEcCtD
Celecoxib—Muscle spasms—Lamivudine—hepatitis B	0.000339	0.00208	CcSEcCtD
Celecoxib—Dizziness—Telbivudine—hepatitis B	0.000337	0.00207	CcSEcCtD
Celecoxib—Anaemia—Lamivudine—hepatitis B	0.000326	0.002	CcSEcCtD
Celecoxib—Vomiting—Telbivudine—hepatitis B	0.000324	0.00199	CcSEcCtD
Celecoxib—Angioedema—Lamivudine—hepatitis B	0.000322	0.00198	CcSEcCtD
Celecoxib—Rash—Telbivudine—hepatitis B	0.000322	0.00198	CcSEcCtD
Celecoxib—Dermatitis—Telbivudine—hepatitis B	0.000321	0.00197	CcSEcCtD
Celecoxib—Headache—Telbivudine—hepatitis B	0.00032	0.00196	CcSEcCtD
Celecoxib—CYP3A4—liver—hepatitis B	0.000319	0.00603	CbGeAlD
Celecoxib—Vertigo—Lamivudine—hepatitis B	0.000317	0.00194	CcSEcCtD
Celecoxib—Syncope—Lamivudine—hepatitis B	0.000316	0.00194	CcSEcCtD
Celecoxib—Leukopenia—Lamivudine—hepatitis B	0.000315	0.00194	CcSEcCtD
Celecoxib—CYP2D6—liver—hepatitis B	0.000314	0.00594	CbGeAlD
Celecoxib—Loss of consciousness—Lamivudine—hepatitis B	0.00031	0.0019	CcSEcCtD
Celecoxib—Cough—Lamivudine—hepatitis B	0.000308	0.00189	CcSEcCtD
Celecoxib—Nausea—Telbivudine—hepatitis B	0.000303	0.00186	CcSEcCtD
Celecoxib—Chest pain—Lamivudine—hepatitis B	0.0003	0.00184	CcSEcCtD
Celecoxib—Myalgia—Lamivudine—hepatitis B	0.0003	0.00184	CcSEcCtD
Celecoxib—Arthralgia—Lamivudine—hepatitis B	0.0003	0.00184	CcSEcCtD
Celecoxib—Anxiety—Lamivudine—hepatitis B	0.000299	0.00184	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000298	0.00183	CcSEcCtD
Celecoxib—Dry mouth—Lamivudine—hepatitis B	0.000293	0.0018	CcSEcCtD
Celecoxib—Confusional state—Lamivudine—hepatitis B	0.00029	0.00178	CcSEcCtD
Celecoxib—Anaphylactic shock—Lamivudine—hepatitis B	0.000288	0.00177	CcSEcCtD
Celecoxib—Oedema—Lamivudine—hepatitis B	0.000288	0.00177	CcSEcCtD
Celecoxib—Infection—Lamivudine—hepatitis B	0.000286	0.00175	CcSEcCtD
Celecoxib—Shock—Lamivudine—hepatitis B	0.000283	0.00174	CcSEcCtD
Celecoxib—Nervous system disorder—Lamivudine—hepatitis B	0.000282	0.00173	CcSEcCtD
Celecoxib—Thrombocytopenia—Lamivudine—hepatitis B	0.000282	0.00173	CcSEcCtD
Celecoxib—Skin disorder—Lamivudine—hepatitis B	0.000279	0.00172	CcSEcCtD
Celecoxib—Hyperhidrosis—Lamivudine—hepatitis B	0.000278	0.00171	CcSEcCtD
Celecoxib—Anorexia—Lamivudine—hepatitis B	0.000274	0.00168	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000262	0.00161	CcSEcCtD
Celecoxib—Insomnia—Lamivudine—hepatitis B	0.00026	0.0016	CcSEcCtD
Celecoxib—Paraesthesia—Lamivudine—hepatitis B	0.000258	0.00159	CcSEcCtD
Celecoxib—Dyspnoea—Lamivudine—hepatitis B	0.000256	0.00157	CcSEcCtD
Celecoxib—Somnolence—Lamivudine—hepatitis B	0.000256	0.00157	CcSEcCtD
Celecoxib—Dyspepsia—Lamivudine—hepatitis B	0.000253	0.00155	CcSEcCtD
Celecoxib—Decreased appetite—Lamivudine—hepatitis B	0.00025	0.00154	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000248	0.00152	CcSEcCtD
Celecoxib—Fatigue—Lamivudine—hepatitis B	0.000248	0.00152	CcSEcCtD
Celecoxib—Constipation—Lamivudine—hepatitis B	0.000246	0.00151	CcSEcCtD
Celecoxib—Feeling abnormal—Lamivudine—hepatitis B	0.000237	0.00146	CcSEcCtD
Celecoxib—Gastrointestinal pain—Lamivudine—hepatitis B	0.000235	0.00144	CcSEcCtD
Celecoxib—Urticaria—Lamivudine—hepatitis B	0.000228	0.0014	CcSEcCtD
Celecoxib—Body temperature increased—Lamivudine—hepatitis B	0.000227	0.0014	CcSEcCtD
Celecoxib—Abdominal pain—Lamivudine—hepatitis B	0.000227	0.0014	CcSEcCtD
Celecoxib—Hypersensitivity—Lamivudine—hepatitis B	0.000212	0.0013	CcSEcCtD
Celecoxib—Asthenia—Lamivudine—hepatitis B	0.000206	0.00127	CcSEcCtD
Celecoxib—Pruritus—Lamivudine—hepatitis B	0.000203	0.00125	CcSEcCtD
Celecoxib—Diarrhoea—Lamivudine—hepatitis B	0.000197	0.00121	CcSEcCtD
Celecoxib—Dizziness—Lamivudine—hepatitis B	0.00019	0.00117	CcSEcCtD
Celecoxib—Vomiting—Lamivudine—hepatitis B	0.000183	0.00112	CcSEcCtD
Celecoxib—Rash—Lamivudine—hepatitis B	0.000181	0.00111	CcSEcCtD
Celecoxib—Dermatitis—Lamivudine—hepatitis B	0.000181	0.00111	CcSEcCtD
Celecoxib—Headache—Lamivudine—hepatitis B	0.00018	0.00111	CcSEcCtD
Celecoxib—Nausea—Lamivudine—hepatitis B	0.000171	0.00105	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—RIT2—hepatitis B	4.43e-05	0.000426	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SAG—hepatitis B	4.43e-05	0.000426	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CCR5—hepatitis B	4.42e-05	0.000425	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD8A—hepatitis B	4.41e-05	0.000424	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	4.4e-05	0.000423	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	4.36e-05	0.000419	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TGFB1—hepatitis B	4.36e-05	0.000419	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CD4—hepatitis B	4.35e-05	0.000419	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—hepatitis B	4.35e-05	0.000418	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GGT1—hepatitis B	4.27e-05	0.000411	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GOT1—hepatitis B	4.27e-05	0.000411	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	4.24e-05	0.000408	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD4—hepatitis B	4.18e-05	0.000402	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—F2—hepatitis B	4.18e-05	0.000401	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GOT2—hepatitis B	4.17e-05	0.000401	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—hepatitis B	4.14e-05	0.000398	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—IL6—hepatitis B	4.13e-05	0.000397	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—TGFB1—hepatitis B	4.08e-05	0.000392	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—hepatitis B	4.07e-05	0.000391	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SAG—hepatitis B	4.04e-05	0.000389	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOBEC3G—hepatitis B	4.04e-05	0.000389	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	4e-05	0.000384	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-A—hepatitis B	3.94e-05	0.000378	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.93e-05	0.000378	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—F2—hepatitis B	3.92e-05	0.000377	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—hepatitis B	3.91e-05	0.000376	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	3.88e-05	0.000373	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS2—hepatitis B	3.87e-05	0.000373	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTNNB1—hepatitis B	3.87e-05	0.000372	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	3.82e-05	0.000367	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—HNF4A—hepatitis B	3.81e-05	0.000366	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—F2—hepatitis B	3.79e-05	0.000365	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—IL6—hepatitis B	3.79e-05	0.000364	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CDKN1A—hepatitis B	3.78e-05	0.000363	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—IL6—hepatitis B	3.78e-05	0.000363	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—PTEN—hepatitis B	3.77e-05	0.000362	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NFKB1—hepatitis B	3.75e-05	0.000361	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CCR5—hepatitis B	3.73e-05	0.000358	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	3.69e-05	0.000355	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.67e-05	0.000353	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CDKN1A—hepatitis B	3.67e-05	0.000353	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—NFKB1—hepatitis B	3.64e-05	0.00035	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HLA-A—hepatitis B	3.63e-05	0.000349	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CDKN1A—hepatitis B	3.63e-05	0.000349	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—PTEN—hepatitis B	3.62e-05	0.000348	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GGT1—hepatitis B	3.6e-05	0.000346	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GOT1—hepatitis B	3.6e-05	0.000346	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NFKB1—hepatitis B	3.6e-05	0.000346	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TLR4—hepatitis B	3.6e-05	0.000346	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-DRB1—hepatitis B	3.6e-05	0.000346	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—hepatitis B	3.59e-05	0.000345	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL6—hepatitis B	3.58e-05	0.000344	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GGT1—hepatitis B	3.55e-05	0.000341	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ALB—hepatitis B	3.53e-05	0.000339	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—hepatitis B	3.53e-05	0.000339	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	3.52e-05	0.000338	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	3.5e-05	0.000336	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TGFB1—hepatitis B	3.47e-05	0.000334	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—hepatitis B	3.45e-05	0.000331	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	3.44e-05	0.000331	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—CDKN1A—hepatitis B	3.44e-05	0.000331	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ALB—hepatitis B	3.44e-05	0.000331	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ALB—hepatitis B	3.44e-05	0.000331	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—PTEN—hepatitis B	3.43e-05	0.00033	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—F2—hepatitis B	3.43e-05	0.00033	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NFKB1—hepatitis B	3.42e-05	0.000329	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS2—hepatitis B	3.39e-05	0.000326	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL10—hepatitis B	3.37e-05	0.000324	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HSPA5—hepatitis B	3.33e-05	0.00032	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—hepatitis B	3.31e-05	0.000318	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HSPA5—hepatitis B	3.28e-05	0.000316	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—hepatitis B	3.26e-05	0.000313	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	3.24e-05	0.000311	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TLR4—hepatitis B	3.21e-05	0.000309	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—hepatitis B	3.21e-05	0.000309	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS2—hepatitis B	3.16e-05	0.000304	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DPB1—hepatitis B	3.15e-05	0.000303	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.12e-05	0.0003	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	3.11e-05	0.000299	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKR1B1—hepatitis B	3.06e-05	0.000294	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—hepatitis B	3.04e-05	0.000292	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	3.04e-05	0.000292	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	3.03e-05	0.000291	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR2—hepatitis B	3.03e-05	0.000291	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—hepatitis B	3.03e-05	0.000291	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	3.02e-05	0.00029	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNB1—hepatitis B	3.01e-05	0.000289	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—hepatitis B	2.97e-05	0.000286	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IFNB1—hepatitis B	2.96e-05	0.000285	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GGT2—hepatitis B	2.94e-05	0.000282	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNA1—hepatitis B	2.93e-05	0.000282	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IFNA1—hepatitis B	2.89e-05	0.000278	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—hepatitis B	2.86e-05	0.000275	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—hepatitis B	2.85e-05	0.000274	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—hepatitis B	2.85e-05	0.000274	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—hepatitis B	2.82e-05	0.000271	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—hepatitis B	2.81e-05	0.00027	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	2.79e-05	0.000268	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—hepatitis B	2.78e-05	0.000267	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNA2—hepatitis B	2.73e-05	0.000262	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD14—hepatitis B	2.73e-05	0.000262	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTEN—hepatitis B	2.69e-05	0.000259	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IFNA2—hepatitis B	2.69e-05	0.000259	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—hepatitis B	2.64e-05	0.000254	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—hepatitis B	2.63e-05	0.000252	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTEN—hepatitis B	2.62e-05	0.000252	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTEN—hepatitis B	2.62e-05	0.000252	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCR5—hepatitis B	2.61e-05	0.000251	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—hepatitis B	2.55e-05	0.000245	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—hepatitis B	2.54e-05	0.000244	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.52e-05	0.000242	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.51e-05	0.000241	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—hepatitis B	2.5e-05	0.00024	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKR1B1—hepatitis B	2.48e-05	0.000238	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTEN—hepatitis B	2.45e-05	0.000235	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GGT2—hepatitis B	2.38e-05	0.000228	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—hepatitis B	2.37e-05	0.000228	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—hepatitis B	2.35e-05	0.000226	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.35e-05	0.000225	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—hepatitis B	2.34e-05	0.000225	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—hepatitis B	2.33e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL18—hepatitis B	2.33e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40LG—hepatitis B	2.32e-05	0.000223	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	2.32e-05	0.000223	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—hepatitis B	2.31e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—hepatitis B	2.29e-05	0.000221	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—hepatitis B	2.29e-05	0.00022	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CTNNB1—hepatitis B	2.28e-05	0.000219	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—hepatitis B	2.27e-05	0.000219	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTEN—hepatitis B	2.27e-05	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—hepatitis B	2.26e-05	0.000217	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTNNB1—hepatitis B	2.25e-05	0.000217	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—F2—hepatitis B	2.24e-05	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NFKB1—hepatitis B	2.21e-05	0.000212	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDKN1A—hepatitis B	2.2e-05	0.000212	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PTEN—hepatitis B	2.2e-05	0.000211	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NFKB1—hepatitis B	2.18e-05	0.00021	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—hepatitis B	2.15e-05	0.000206	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CTNNB1—hepatitis B	2.08e-05	0.0002	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.07e-05	0.000199	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.06e-05	0.000198	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—hepatitis B	2.06e-05	0.000198	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKR1B1—hepatitis B	2.05e-05	0.000197	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-A—hepatitis B	2.04e-05	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CDKN1A—hepatitis B	2.03e-05	0.000195	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKR1B1—hepatitis B	2.03e-05	0.000195	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTEN—hepatitis B	2.03e-05	0.000195	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTNNB1—hepatitis B	2.01e-05	0.000193	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CDKN1A—hepatitis B	1.96e-05	0.000189	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GGT2—hepatitis B	1.96e-05	0.000189	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PTEN—hepatitis B	1.96e-05	0.000188	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NFKB1—hepatitis B	1.95e-05	0.000187	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GGT2—hepatitis B	1.94e-05	0.000187	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GOT2—hepatitis B	1.92e-05	0.000185	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—hepatitis B	1.92e-05	0.000184	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR4—hepatitis B	1.87e-05	0.00018	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—hepatitis B	1.87e-05	0.00018	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—hepatitis B	1.84e-05	0.000177	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTEN—hepatitis B	1.81e-05	0.000174	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	1.81e-05	0.000174	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—hepatitis B	1.8e-05	0.000173	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2A6—hepatitis B	1.78e-05	0.000171	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—F2—hepatitis B	1.77e-05	0.000171	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—hepatitis B	1.75e-05	0.000169	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL10—hepatitis B	1.75e-05	0.000168	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTEN—hepatitis B	1.73e-05	0.000167	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—hepatitis B	1.72e-05	0.000165	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—hepatitis B	1.7e-05	0.000163	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—hepatitis B	1.68e-05	0.000162	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.66e-05	0.000159	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GOT1—hepatitis B	1.66e-05	0.000159	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GOT2—hepatitis B	1.61e-05	0.000155	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—hepatitis B	1.51e-05	0.000145	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—hepatitis B	1.5e-05	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—hepatitis B	1.48e-05	0.000143	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTEN—hepatitis B	1.46e-05	0.000141	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CTNNB1—hepatitis B	1.46e-05	0.00014	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2A6—hepatitis B	1.44e-05	0.000138	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN1A—hepatitis B	1.42e-05	0.000137	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTEN—hepatitis B	1.42e-05	0.000136	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NFKB1—hepatitis B	1.41e-05	0.000136	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GOT1—hepatitis B	1.39e-05	0.000133	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GGT1—hepatitis B	1.39e-05	0.000133	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—hepatitis B	1.39e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—hepatitis B	1.37e-05	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—hepatitis B	1.36e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—hepatitis B	1.36e-05	0.00013	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.34e-05	0.000129	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—hepatitis B	1.32e-05	0.000127	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GOT2—hepatitis B	1.3e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GGT2—hepatitis B	1.28e-05	0.000123	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—hepatitis B	1.27e-05	0.000122	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.27e-05	0.000122	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—hepatitis B	1.24e-05	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—hepatitis B	1.22e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—hepatitis B	1.21e-05	0.000117	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HLA-A—hepatitis B	1.21e-05	0.000116	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—hepatitis B	1.2e-05	0.000115	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.19e-05	0.000114	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2A6—hepatitis B	1.18e-05	0.000113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—hepatitis B	1.18e-05	0.000113	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTNNB1—hepatitis B	1.17e-05	0.000113	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—F2—hepatitis B	1.16e-05	0.000112	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDKN1A—hepatitis B	1.14e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTEN—hepatitis B	1.14e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKB1—hepatitis B	1.14e-05	0.000109	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GGT1—hepatitis B	1.12e-05	0.000108	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GOT1—hepatitis B	1.12e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.1e-05	0.000106	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GOT2—hepatitis B	1.07e-05	0.000103	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GOT2—hepatitis B	1.07e-05	0.000102	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—hepatitis B	1.05e-05	0.000101	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.02e-05	9.84e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—hepatitis B	9.69e-06	9.31e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—hepatitis B	9.32e-06	8.96e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GGT1—hepatitis B	9.28e-06	8.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GOT1—hepatitis B	9.28e-06	8.92e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GOT1—hepatitis B	9.19e-06	8.84e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GGT1—hepatitis B	9.19e-06	8.84e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—hepatitis B	8.87e-06	8.52e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.38e-06	8.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—hepatitis B	7.84e-06	7.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—hepatitis B	7.77e-06	7.47e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2A6—hepatitis B	7.77e-06	7.47e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—hepatitis B	7.67e-06	7.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CTNNB1—hepatitis B	7.57e-06	7.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1A—hepatitis B	7.39e-06	7.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—hepatitis B	7.39e-06	7.1e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTEN—hepatitis B	7.38e-06	7.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKB1—hepatitis B	7.34e-06	7.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—hepatitis B	7.13e-06	6.85e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GOT2—hepatitis B	7.02e-06	6.75e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CTNNB1—hepatitis B	6.9e-06	6.64e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1A—hepatitis B	6.74e-06	6.48e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTEN—hepatitis B	6.73e-06	6.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—hepatitis B	6.11e-06	5.88e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GOT1—hepatitis B	6.06e-06	5.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GGT1—hepatitis B	6.06e-06	5.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTEN—hepatitis B	5.63e-06	5.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—hepatitis B	5.58e-06	5.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—hepatitis B	5.03e-06	4.84e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—hepatitis B	4.93e-06	4.74e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—hepatitis B	4.89e-06	4.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—hepatitis B	4.61e-06	4.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTEN—hepatitis B	4.56e-06	4.38e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—hepatitis B	4.2e-06	4.04e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTEN—hepatitis B	3.76e-06	3.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTEN—hepatitis B	3.73e-06	3.59e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—hepatitis B	3.23e-06	3.1e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTEN—hepatitis B	2.46e-06	2.37e-05	CbGpPWpGaD
